HCPCS code J2930: Deleted, bill J2919 at 5 mg instead

Key takeaways

HCPCS code J2930 covered injectable methylprednisolone sodium succinate, up to 125 mg. CMS deleted it for dates of service from April 1, 2024.

J2920 described the same drug at up to 40 mg, and it went on the same date. One code replaced both.

J2919 reads injection, methylprednisolone sodium succinate, 5 mg. Divide the milligrams given by 5 to get the units.

A 1,000 mg infusion now reports 200 units. The old J2930 math would have billed the same dose as 8.

Every J2919 line needs modifier JW when drug was discarded from a single-dose vial, or JZ when none was.

Depo-Medrol is a different salt. Methylprednisolone acetate bills under J1010 at 1 mg per unit, not under J2919.

HCPCS code J2930 no longer exists. It covered injectable methylprednisolone sodium succinate, up to 125 mg, and CMS deleted it for dates of service from April 1, 2024. J2920 went on the same day. CMS replaced both with a single code, J2919, described as injection, methylprednisolone sodium succinate, 5 mg.

That 5 mg unit is what catches billers out. A 1,000 mg infusion now reports 200 units, where the old code took 8. Keep the old math and the practice underbills by thousands without ever seeing a denial.

Below you will find the former descriptor, the new unit math, where each field goes on the claim, and the denials worth fixing first.

What HCPCS code J2930 described before it was deleted

J2930 was a Level II J-code maintained by the Centers for Medicare and Medicaid Services (CMS). It reported injectable methylprednisolone sodium succinate on outpatient claims, and it was valid through March 31, 2024.

The table records the descriptor as it stood on its final valid day.

The drug itself has not changed. Methylprednisolone sodium succinate is a water-soluble corticosteroid, given for acute inflammatory conditions, autoimmune flares, and immunosuppressive regimens.

Because it is injected rather than swallowed, it sits in HCPCS Level II rather than under a CPT code. J-codes cover non-oral drugs and biologicals a patient cannot self-administer.

J2930 and J2920 both stopped being billable on April 1, 2024

CMS removed J2930 and J2920 in the April 2024 HCPCS quarterly update and added J2919 the same day. Neither deleted code has a dose-specific successor to look up.

One code now covers the whole strength range, and the unit does the work the old tiers used to do.

Dates of service matter more than submission dates here. An infusion given on or before March 31, 2024 still belongs on J2930 or J2920, and that holds for late filings and reworked denials too. Any date of service from April 1, 2024 onward belongs on J2919.

A deleted code denies as CARC 181

Filing J2930 on a current date of service produces claim adjustment reason code 181: procedure code was invalid on the date of service.

The edit is automatic, so no clinical review or medical necessity argument is involved. Your remittance names the code as the problem, not the documentation.

The correction is a rebill rather than an appeal. Swap J2930 for J2919, recalculate the units at 5 mg each, then resubmit with the same NDC and administration record.

Telling the two routes apart starts with the reason code, and our guide to denial codes maps the ones a biller meets most often.

Clean the charge master before the next claim goes out

Deleted-code denials usually trace back to a stale charge master rather than a coder’s mistake. Three checks close the loop:

• Retire the old codes: delete or deactivate J2920 and J2930 in the charge master, the EHR charge capture screen, and any printed superbill
• Rebuild the multiplier: set the J2919 line to convert milligrams to units at 5 mg each, then test it on a 1,000 mg order
• Rework open receivables: pull every unpaid claim still sitting on J2920 or J2930 with a 2024 or later date of service, and rebill the batch

Off-cycle deletions like this one are easy to miss, because code file audits usually happen each January. This change landed in April. Checking the CMS quarterly HCPCS update every three months catches the next one sooner.

J2919 bills per 5 mg, so divide the dose by five

One unit of J2919 equals 5 mg of methylprednisolone sodium succinate. There is no “up to” language in the descriptor and no tier to choose. Take the milligrams documented as administered, divide by 5, then report that figure in the units field.

The right-hand column is there for one reason. A remittance showing 8 units paid on a 1,000 mg infusion means the claim went out on the old tiered logic.

The practice was paid for 40 mg of drug. Under-billing at that scale is invisible on a single claim and expensive across a pulse therapy course.

Round odd doses up, then flag the waste

Round up to the next whole unit, and never round down to a tidier number. Most standard orders divide cleanly by 5, but weight-based pediatric doses often do not. A 62 mg dose works out to 12.4 units, so 13 units go on the claim.

Discarded drug bills separately from administered drug. When a single-dose vial leaves a remainder, report the wasted milligrams on their own line with modifier JW. Document the discarded amount in the record as well, and keep the administered milligrams on the primary line.

One of two modifiers belongs on every single-dose-vial line, and this has been mandatory since July 1, 2023. Use JW when drug was discarded, and JZ when none was. Since October 1, 2023, CMS returns single-dose-vial claims unprocessable when neither modifier is present.

Sodium succinate and acetate are two separate code families

Methylprednisolone comes in two injectable salts, and each has its own HCPCS family. Mixing them is the oldest error on this drug, and the April 2024 update rewrote both families at once.

Two points are worth holding on to. J2920 was never the acetate code, despite how often it gets described that way. It carried the same sodium succinate descriptor as J2930, only at a lower milligram tier. The acetate codes have always run in the J10xx range, and CMS folded J1040 into J1010 on the same date.

The practical check is the vial, not the code book. A clear solution reconstituted from powder is sodium succinate and bills as J2919. The white suspension you shake before drawing up is acetate and bills as J1010. The unit basis differs too, at 5 mg for one and 1 mg for the other.

Medicare pays J2919 from the ASP file, updated every quarter

Medicare Part B covers outpatient drug injections a patient cannot self-administer. IV methylprednisolone sodium succinate given in a physician office or hospital outpatient department qualifies. Confirm the patient’s Part B benefit for that setting and diagnosis before the infusion date, not after it.

Payment runs on the Average Sales Price methodology. CMS publishes quarterly ASP files that set the office-setting allowance at ASP plus 6%, and hospital outpatient departments are paid under OPPS instead.

The per-unit rate is now expressed per 5 mg, so a payment limit that looks small on paper multiplies across a high unit count.

Medicaid coverage varies by state. Many state programs use the same J-codes, but allowed amounts and coverage criteria differ, and some states were slow to load J2919. Check the state fee schedule or the MAC portal before you assume Medicare rates apply.

The NDC rides in loop 2410, not the procedure code field

Medicare and most commercial payers want the National Drug Code reported next to the HCPCS code on drug claims. The NDC is manufacturer-specific and names the exact product, package size, and labeler. Several manufacturers make methylprednisolone sodium succinate, and every one of those NDCs maps to J2919.

On an 837P electronic claim, the NDC goes in loop 2410 in the LIN segment, with the N4 qualifier ahead of the 11-digit number. The CTP segment in the same loop carries the drug quantity and unit of measure. Outside that loop, the SV1 segment holds the code, any modifier, and the unit count.

On the CMS-1500 paper form, the same information splits across box 24. The NDC goes in the shaded area of box 24A. Box 24D holds the procedure code and its modifier, and box 24G holds the unit count. Sending one of those to the wrong field is a rejection, not a denial.

Six NDC rules that keep the line clean

• Report the NDC as an 11-digit number in 5-4-2 format, not the 10-digit format printed on the carton
• Send the N4 qualifier in the LIN segment ahead of the NDC on the 837P
• Report the drug quantity with a unit of measure qualifier, usually ML for a reconstituted solution or UN for a vial
• Keep the NDC quantity separate from the J2919 unit count, since the two figures measure different things
• Retain the vial label or its scanned image in the patient record as supporting documentation
• Verify the pairing against the CMS ASP NDC-HCPCS crosswalk, which is refreshed each quarter

What the record has to show before you bill J2919

Payers pay J2919 on the strength of the administration record. The note has to show that the injection was clinically appropriate on that date of service, and it has to state the dose in milligrams.

A superbill for an injection practice should carry fields for dose, route, time, and the diagnosis that justifies the drug.

• Physician order: a signed order naming the drug, the dose in milligrams, the route, and the frequency
• Diagnosis linkage: an ICD-10-CM code that supports medical necessity. Examples include M06.9 for rheumatoid arthritis, G35 for a multiple sclerosis relapse, and J45.51 for severe persistent asthma with acute exacerbation
• Administration record: date, time, milligrams given, route, site, and the name of the clinician who gave it
• NDC and lot number: transcribed or scanned from the vial label, for payer audits and product recalls
• Clinical rationale: the presentation that prompted the infusion and the reason for the dose chosen
• Waste record: the milligrams discarded from a single-dose vial, reported on a separate JW line where the payer allows it

Record retention runs to seven years in most states, and payer contracts sometimes ask for longer. Store the administration record and the vial documentation together, because auditors read them as one exhibit.

Which specialties push J2919 unit counts highest

Rheumatology and neurology run the highest unit counts, because pulse dosing is routine in both. The drug crosses plenty of other specialties too, and the billing context shifts with each one.

• Rheumatology: IV pulse therapy for rheumatoid arthritis flares, systemic lupus erythematosus, and vasculitis, often alongside disease-modifying antirheumatic drugs
• Neurology: acute multiple sclerosis relapses and optic neuritis, commonly 1,000 mg daily for three to five days, which is 200 units of J2919 per day
• Pulmonology and emergency medicine: severe asthma exacerbations, anaphylaxis, and COPD exacerbations treated in outpatient or observation settings
• Oncology and transplant medicine: immunosuppressive regimens for graft-versus-host disease, usually paired with other drugs that need their own J-codes
• Dermatology: pemphigus vulgaris and toxic epidermal necrolysis, where the diagnosis code has to be confirmed condition by condition
• Allergy and immunology: acute management of severe allergic reactions in the office

Local and national coverage determinations set out which ICD-10-CM codes support medical necessity for corticosteroid injections in each region. Read the applicable LCD before billing, especially for repeat pulse courses, which draw more scrutiny than a single dose.

Five errors behind most methylprednisolone claim denials

Denials on this drug repeat in a narrow set of patterns. Knowing them lets a team build pre-submission checks instead of reworking the same rejection every month.

Track the denial rate on this drug month by month. A rate above 5% points at the code file or the unit conversion, rarely at one person’s typing.

Run these five checks before the claim goes out

You can catch most J2919 problems at the desk in under a minute. Run the line through this list before the batch is released.

• Code matches the date: J2919 for any date of service from April 1, 2024, and J2930 or J2920 only for dates through March 31, 2024
• Units recalculated: milligrams from the administration record divided by 5, rounded up to the next whole unit
• Waste modifier attached: JW when drug was discarded from a single-dose vial, JZ when none was
• NDC in the right field: 11 digits in 5-4-2 format behind the N4 qualifier, in box 24A shaded or loop 2410
• Diagnosis supports the drug: an ICD-10-CM code the applicable LCD lists for corticosteroid injection

A line that fails one of these gets fixed before submission, not after the remittance arrives.

How Pabau keeps corticosteroid claims moving

In a lot of practices, drug claims live in two disconnected places. The dose sits in the clinical note, the code and units sit in a billing screen, and somebody retypes one into the other. That handoff is where a 125 mg entry becomes 1 unit instead of 25.

Practice management software like Pabau keeps the injection record and the claim in the same system. The dose, route, site, and indication recorded at the point of care stay on the client’s chart. Whoever prepares the claim reads the original note rather than a retyped copy.

Pabau’s claims management software then files the claim electronically through the clearinghouse for your region.

Before it goes, Pabau checks that the required claim fields are complete, including membership numbers and authorization codes. Incomplete claims stop at your desk instead of coming back weeks later as a rejection.

Keep injection records and claims in one system

Practice management software like Pabau keeps dose, route, site, and indication on the client record. Claims then file electronically, with a check on the required fields before anything is sent.

Book a demo

Conclusion

Learning the new code takes a minute. Trusting it takes longer, because a 200-unit line looks wrong to anyone who billed the same infusion as 8. Coders who grew up on the “up to 125 mg” tiers will keep second-guessing that number. A claim held back for a second look is a claim that ages.

So fix it once in the charge master rather than case by case at the keyboard. Build the J2919 line so it calculates its own units from the documented milligrams. That takes the judgment out of the moment, and it protects the doses nobody flags. Under-billing never bounces back, which is exactly why it survives.

That fix only holds if the milligrams are written down clearly in the first place. Pabau keeps the injection record and the claim in one place, then checks the required fields before submission. Book a demo to see how that works for the drug claims your practice sends every week.

Continue your research

Need to understand how denials work across all billing codes? Denial management in healthcare covers the full appeal process, common payer denial patterns, and how to build a denial tracking workflow.

Looking for a structured approach to clean claim submission? Electronic remittance advice explains how to read ERA files, interpret adjustment reason codes, and reconcile payments against billed HCPCS units.

Billing another corticosteroid injection? HCPCS code J1040 walks through the parallel methylprednisolone acetate deletion and the single J1010 replacement code.

Frequently asked questions